Literature DB >> 10678502

Anti-inflammatory and antinociceptive effects in rodents of the essential oil of Croton cajucara Benth.

E J Bighetti1, C A Hiruma-Lima, J S Gracioso, A R Brito.   

Abstract

The plant Croton cajucara Benth. (Euphorbiaceae) is widely used in Amazonian folk medicine for the treatment of a wide range of illnesses. In this investigation the analgesic and anti-inflammatory properties of the essential oil from the bark of C. cajucara Benth., administered orally, were determined in several standard rodent models of pain and inflammation. We observed that pretreatment with essential oil significantly reduced the latency of sleeping time evoked by pentobarbital compared with the control group (P < 0.001). Doses of 100 or 1000 mg kg(-1) also increased the sleeping time induced by pentobarbital (30.9 +/- 3.91 and 52.1 +/- 15.6 min, respectively) compared with the negative control (12.4 +/- 4.27 min). We investigated the antinociceptive effect of the essential oil in chemical (acetic acid) and thermal (hot-plate) models of nociception in mice. Dipyrone (200 mg kg(-1)) and the highest doses of the essential oil (1000 mg kg(-1)) significantly inhibited acetic acid-induced abdominal constriction in mice (5.00 +/- 1.38 and 6.8 +/- 2.1 constrictions, respectively) compared with the negative control (33.1 +/- 2). The same dose of essential oil also raised the pain thresholds of mice in the hot-plate test and significantly (P < 0.05) increased the latency at all observation times. In acetic acid-induced abdominal constriction in mice pretreatment of the animals with naloxone (5 mg kg(-1)) significantly reversed the analgesic effect of morphine and of the essential oil at the highest dose (1000 mg kg(-1)). The essential oil of C. cajucara was also investigated for its anti-inflammatory properties. At the lowest dose (100 mg kg(-1)) the essential oil had anti-inflammatory effects in animal models of acute (carrageenin-induced paw oedema in mice) and chronic (cotton pellet granuloma) inflammation. The essential oil at doses of 50, 100 and 200 mg kg(-1) significantly and dose-dependently inhibited carrageenan-induced oedema (49 +/- 5; 37 +/- 5; 34 +/- 8 mg, respectively) compared with the negative control (74 +/- 8 mg). The essential oil (100 mg kg(-1)) also inhibited chronic inflammation by 38% whereas diclofenac inhibited it by 36%. However, the essential oil did not inhibit the migration of neutrophils into the peritoneal cavity. These data show that the essential oil from C. cajucara contains compounds that had a significant antinociceptive effect when the oil was administered at the highest dose. This effect seems to be related to interaction with the opioid system. The essential oil also had a significant anti-inflammatory effect in acute and chronic inflammation models when administered at lower doses. This effect seems to be related to cyclooxygenase inhibition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10678502     DOI: 10.1211/0022357991777100

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  9 in total

1.  The anti-arthritic and anti-oxidative effect of NBD (6-nitro-1,3-benzodioxane) in adjuvant-induced arthritis (AIA) in rats.

Authors:  Syed Uzair Ali Shah; Nadeem Ashraf; Zahid H Soomro; Muhammad Raza Shah; Nurul Kabir; Shabana Usman Simjee
Journal:  Inflamm Res       Date:  2012-04-27       Impact factor: 4.575

2.  Antinociceptive activity of Hypericum grandifolium Choisy in mice.

Authors:  Celia Xiomara Bonkanka; Candelaria Del Carmen Sánchez-Mateo; Rosa María Rabanal
Journal:  J Nat Med       Date:  2010-10-16       Impact factor: 2.343

Review 3.  Database survey of anti-inflammatory plants in South America: a review.

Authors:  Gedson Rodrigues de Morais Lima; Camila de Albuquerque Montenegro; Cynthia Layse Ferreira de Almeida; Petrônio Filgueiras de Athayde-Filho; José Maria Barbosa-Filho; Leônia Maria Batista
Journal:  Int J Mol Sci       Date:  2011-04-21       Impact factor: 5.923

4.  Antileishmanial activity of a linalool-rich essential oil from Croton cajucara.

Authors:  Maria do Socorro S do Socorro S Rosa; Ricardo R Mendonça-Filho; Humberto R Bizzo; Igor de Almeida Rodrigues; Rosangela Maria A Soares; Thais Souto-Padrón; Celuta Sales Alviano; Angela Hampshire C S Lopes
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

5.  Antinociceptive Effect of the Essential Oil Obtained from the Leaves of Croton cordiifolius Baill. (Euphorbiaceae) in Mice.

Authors:  Lenise de Morais Nogueira; Monalisa Ribeiro da Silva; Simone Maria Dos Santos; Julianna Ferreira Cavalcanti de Albuquerque; Igor Cavalcanti Ferraz; Thaíse Torres de Albuquerque; Carlos Renato França de Carvalho Mota; Renata Mendonça Araújo; Glauce Socorro de Barros Viana; René Duarte Martins; Alexandre Havt; Rafael Matos Ximenes
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-02       Impact factor: 2.629

6.  Effect of Citrus aurantium L. Essential Oil on Streptococcus mutans Growth, Biofilm Formation and Virulent Genes Expression.

Authors:  Chahrazed Benzaid; Amine Belmadani; Lazhari Tichati; Ryad Djeribi; Mahmoud Rouabhia
Journal:  Antibiotics (Basel)       Date:  2021-01-08

Review 7.  Anti-Inflammatory Medicinal Plants of Bangladesh-A Pharmacological Evaluation.

Authors:  Most Afia Akhtar
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810

8.  Pharmacological evaluation of the gabapentin salicylaldehyde derivative, gabapentsal, against tonic and phasic pain models, inflammation, and pyrexia.

Authors:  Nisar Ahmad; Fazal Subhan; Nazar Ul Islam; Muhammad Shahid; Naseem Ullah; Rahim Ullah; Muhammad Khurram; Muhammad Usman Amin; Shehla Akbar; Ihsan Ullah; Robert D E Sewell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-07-12       Impact factor: 3.000

9.  Cartilage protective and anti-analgesic effects of ALM16 on monosodium iodoacetate induced osteoarthritis in rats.

Authors:  Doo Jin Choi; Soo-Im Choi; Bo-Ram Choi; Young-Seob Lee; Dae Young Lee; Geum Soog Kim
Journal:  BMC Complement Altern Med       Date:  2019-11-21       Impact factor: 3.659

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.